Drug resistance in patients experiencing early virological failure under a triple combination including indinavir-Reference-Cited by-同舟云学术

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

Published:2001-09 Issue:13 Volume:15 Page:1701-1706
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Gallego Oscar,de Mendoza Carmen,Pérez-Elías María Jesús,Guardiola Josep María,Pedreira José,Dalmau David,Gónzalez Juan,Moreno Ana,Arribas José Ramón,Rubio Amalia,García-Arata Isabel,Leal Manuel,Domingo Pere,Soriano Vincent

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference33 articles.

1. Antiretroviral Therapy in Adults

2. Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

3. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

4. Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Associations of Mutations within the HIV-1 Env and Gag Genes Conferring Protease Inhibitor (PI) Drug Resistance;Microbiology Research;2021-12-15

2. Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations;mBio;2021-02-23

3. Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations;2020-08-06

4. Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle;Proceedings of the National Academy of Sciences;2019-04-11

5. Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden;The Lancet HIV;2016-04